euroPCR 2014.

The most relevant articles and presentations, daily report from the euroPCR 2014 – May, 20 to 23.

Ernesto Torresani, Ricardo Lluberas, Oscar Mendiz, Jorge Belardi,  José Luis Leiva Pons and Fernando Pineda at the SOLACI@euroPCR Session “Appraisal of new technologies in interventional medicine” held  on Tuesday 20th, in Theatre Havane, under the euroPCR Congress 2014

If you cannot view the articles, click here

More articles by this author

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...